Epidemiology of Reported HIV and Other Sexually Transmitted Infections During the COVID-19 Pandemic, New York City

Braunstein, Sarah L.; Slutsker, Jennifer Sanderson; Lazar, Rachael; Shah, Dhara; Hennessy, Robin R.; Chen, Shirley X.; Pathela, Preeti; Daskalakis, Demetre; Schillinger, Julia A.

doi:10.1093/infdis/jiab319

Cited by 31 publications

(30 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 Their effects on communicable nonrespiratory infections have also been studied, with contradictory results, in particular for sexually transmitted infections. [3][4][5][6][7][8] However, there have been few published data regarding two frequent nonrespiratory communicable infections, head lice and scabies.…”

Section: Introductionmentioning

confidence: 99%

“…As well as the effects in reducing SARS‐CoV‐2 transmission, lockdowns and physical distancing also dramatically limited the circulation of other common communicable respiratory infections such as influenza 2 . Their effects on communicable nonrespiratory infections have also been studied, with contradictory results, in particular for sexually transmitted infections 3–8 . However, there have been few published data regarding two frequent nonrespiratory communicable infections, head lice and scabies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France

Launay

Bardoulat

Lemaître

et al. 2022

Clin Experimental Derm

View full text Add to dashboard Cite

Background. Lockdowns and physical distancing have dramatically limited the circulation of SARS-CoV-2 and other common communicable infections. However, little is known about their impact on head lice and scabies. Aim. To assess the impact of the 2020 French National lockdowns (17 March-11 May 2020, and 30 October-15 December 2020) and physical distancing recommendations (from February 2020) on the dynamics of head lice and scabies infestations. Methods. The weekly sales of topical head lice treatments, topical scabies treatments and oral ivermectin were extracted from the database of the healthcare science company IQVIA (60% of all French retail pharmacies) and analysed over a 5-year period (March 2016-December 2020). A periodic regression model was fitted to drug sales before the COVID-19 period (2016-2019) and extrapolated to compare the observed sales in 2020 to the expected sales. Results. A decrease of the sales of tracer topical treatments for head lice and scabies was observed from March 2020, synchronously with the first French national lockdown. For the period March-December 2020, the mean reduction in observed vs. expected sales for head lice and scabies topical treatments was 44% and 14%, respectively. By contrast, although there was an observed decrease in oral ivermectin sales after March 2020, it was much lower (4%), probably because of studies reporting the potential positive effects of this drug on COVID-19 infection. Conclusion. COVID-19 lockdown and physical distancing reduce circulation of head lice and scabies in France. Further studies are needed to assess the long-term impact of these social behaviour changes.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France

Launay

Bardoulat

Lemaître

et al. 2022

Clin Experimental Derm

View full text Add to dashboard Cite

show abstract

“…8 Our findings align with analyses conducted in different settings, which have also shown decreases in HIV testing from 2019 to 2020. 4,9,10 Results from a large commercial laboratory reported nearly 670,000 fewer HIV screening tests during March 13-September 30, 2020, compared with the same period in 2019. 9 Among 4 major health care systems in large metropolitan US areas, the number of HIV tests dropped from 40,620 in 2019 to 27,112 in 2020.…”

Section: Discussionmentioning

confidence: 99%

“…During the March 23-June 7, 2020 stay-at-home order, the New York City Department of Health and Mental Hygiene found that reported positive tests for HIV declined markedly in March 2020, reached a low point in April 2020, and rebounded slowly beginning in May 2020. 4 Compared with the same period in 2019, there was a 59% reduction in the number of new HIV diagnoses in 2020.…”

Section: Introductionmentioning

confidence: 99%

HIV Testing Services Outcomes in CDC-Funded Health Departments During COVID-19

Patel

Williams²,

Wright

et al. 2022

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Background:Organizations offering HIV prevention services have reported interruptions during the COVID-19 pandemic. The national extent of these interruptions and their public health impact remain largely unexplored.Methods:Using data from 60 state and local health departments, we compared HIV testing services outcomes in calendar years 2019 and 2020, including the number of Centers for Disease Control and Prevention (CDC)-funded HIV tests conducted, the percentage of persons with newly diagnosed HIV infection (ie, HIV positivity), and the percentage linked to HIV medical care within 30 days after new diagnoses (ie, linkage to care) using χ2 and robust Poisson models. We also assessed the independent associations between the pandemic period (ie, March—December 2020) and the number of COVID-19 cases with monthly HIV testing services outcomes using multivariable robust Poisson models.Results:There was a 46.0% (P < 0.001) reduction in the number of CDC-funded HIV tests conducted in 2020 (n = 1,255,895) compared with 2019 (n = 2,324,421). Although there were fewer persons with newly diagnosed HIV in 2020 (n = 5581 vs. n = 7739 in 2019), HIV positivity was greater in 2020 (0.4% vs. 0.3% in 2019; adjusted prevalence ratio [aPR] = 1.33, 95% confidence interval [CI]: 1.05 to 1.69). When adjusting for the monthly number of COVID-19 cases, the pandemic period was associated with a 56% reduction in the number of monthly CDC-funded HIV tests (adjusted rate ratio = 0.44, 95% CI: 0.37 to 0.52) but 28% higher monthly HIV positivity (aPR = 1.28 95% CI: 1.16 to 1.41) and 10% higher linkage to care (aPR = 1.10, 95% CI: 1.02 to 1.18).Discussion:Despite increased HIV positivity, a drastic reduction in the number of CDC-funded HIV tests was observed in 2020, affecting the ability to identify persons with newly diagnosed HIV. CDC and health departments will need to expand testing strategies to cover tests not conducted in 2020 while adapting to the continuing pandemic.A visual abstract is available for this article at: http://links.lww.com/QAI/B941

show abstract

“…The COVID-19 pandemic has impacted the epidemiology of diverse infectious diseases, including sexually transmitted infections (e.g. HIV),(1) vector-borne illnesses (e.g. dengue virus),(2) and invasive bacterial diseases (e.g.…”

Section: Introductionmentioning

confidence: 99%

Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance

Shirreff

Temime

et al. 2022

Preprint

View full text Add to dashboard Cite

Circulation of multidrug-resistant bacteria (MRB) in healthcare facilities is a major public health problem. These settings have been greatly impacted by the COVID-19 pandemic, notably due to surges in COVID-19 caseloads and the implementation of infection control measures. Yet collateral impacts of pandemic COVID-19 on MRB epidemiology remain poorly understood. Here, we present a dynamic transmission model in which SARS-CoV-2 and MRB co-circulate among patients and staff in a hospital population in an early pandemic context. Responses to SARS-CoV-2 outbreaks are captured mechanistically, reflecting impacts on factors relevant for MRB transmission, including contact behaviour, hand hygiene compliance, antibiotic prescribing and population structure. In a first set of simulations, broad parameter ranges are accounted for, representative of diverse bacterial species and hospital settings. On average, COVID-19 control measures coincide with MRB prevention, including fewer incident cases and fewer cumulative person-days of patient MRB colonization. However, surges in COVID-19 caseloads favour MRB transmission and lead to increased rates of antibiotic resistance, especially in the absence of concomitant control measures. In a second set of simulations, methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli are simulated in specific hospital wards and pandemic response scenarios. Antibiotic resistance dynamics are highly context-specific in these cases, and SARS-CoV-2 outbreaks significantly impact bacterial epidemiology only in facilities with high underlying risk of bacterial transmission. Crucially, antibiotic resistance burden is reduced in facilities with timelier, more effective implementation of COVID-19 control measures. This highlights the control of antibiotic resistance as an important collateral benefit of robust pandemic preparedness.

show abstract

Epidemiology of Reported HIV and Other Sexually Transmitted Infections During the COVID-19 Pandemic, New York City

Cited by 31 publications

References 4 publications

Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France

Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France

HIV Testing Services Outcomes in CDC-Funded Health Departments During COVID-19

Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance

Contact Info

Product

Resources

About